Singlife has unveiled its latest insurance offering, the Singlife Multipay Critical Illness II, designed to provide comprehensive financial support for policyholders at every stage of illness, including recurrent conditions. This plan, available as a standalone policy or as a rider to selected Singlife term plans, boasts a market-leading payout of 150% for each recurrent critical illness claim, covering major conditions such as cancer, stroke, and heart attack.
The plan offers extensive coverage across 135 critical illness conditions, with potential payouts reaching up to 900% of the sum assured. A notable feature is the Advance Care Option, exclusive to Singlife, which allows policyholders diagnosed with a severe stage critical illness to convert their Recurrent Critical Illness Benefit into an additional lump sum payout of 75% of the sum assured. This option provides extra financial security during critical times.
Helen Shen, Group Head of Products at Singlife, stated, “At Singlife, we know that illness can be unpredictable and recovery is often complex. Singlife Multipay Critical Illness II is built to support policyholders through every stage of illness, even after a diagnosis, whether at an early stage or during a recurrence.”
Additionally, the plan includes a premium waiver upon the diagnosis of the first severe stage critical illness, ensuring policyholders are not burdened with future payments during challenging times. This initiative underscores Singlife’s commitment to providing innovative and robust support for its customers.
“`
